Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2026-02-02 @ 3:15 AM
Study NCT ID:
NCT03679650
Status:
RECRUITING
Last Update Posted:
2025-01-24
First Post:
2018-09-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
18-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None